The urokinase-receptor in infectious diseases;Il recettore dell'urochinasi nelle infezioni

Infezioni in Medicina

Volumn 20, Issue SUPPL. 2, 2012, Pages 13-18

  Montuori, Nunzia ^a   Selleri, Carmine ^b   Ragno, Pia ^b  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

Author keywords

uPA; uPAR; Urokinase; Urokinase receptor

Indexed keywords

UROKINASE; UROKINASE RECEPTOR; VITRONECTIN;

ADAPTIVE IMMUNITY; BACTERIAL INFECTION; CELL ADHESION; CELL MEMBRANE; CELL MIGRATION; CELL PROLIFERATION; CELL SURVIVAL; DISEASE SEVERITY; EXTRACELLULAR MATRIX; HUMAN; INNATE IMMUNITY; NONHUMAN; PLASMINOGEN ACTIVATION; PROGNOSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN POLYMORPHISM; PROTEIN STRUCTURE; REVIEW; SURVIVAL RATE; VIRUS INFECTION;

ANIMALS; HUMANS; INFECTION; UROKINASE-TYPE PLASMINOGEN ACTIVATOR;

EID: 84867530766     PISSN: 11249390     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (36)

1. Ragno P. The urokinase receptor: a ligand or a receptor? Story of a sociable molecule. Cell Mol. Life Sci. 63, 1028-1037, 2006.
2. Rijken D.C., Lijnen H.R. New insights into the molecular mechanisms of the fibrinolytic system. J. Thromb. Haemost. 7, 4-13, 2009.
3. Montuori N., Ragno P. Multiple activities of a multifaceted receptor: roles of cleaved and soluble uPAR. Front. Biosci. 14, 2494-2503, 2009.
4. Plesner T., Behrendt N., Ploug M. Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR. Stem Cells. 15, 398-408, 1997.
5. Thunø M., Macho B., Eugen-Olsen J. suPAR the molecular crystal ball. Dis Markers. 27, 157-172, 2009.
6. Vassalli J.D., Baccino D., Belin D. A cellular binding site for the Mr 55,000 form of the human plasminogen activator, urokinase. J. Cell Biol. 100, 86-92, 1985.
7. Roldan A.L., Cubellis M.V., Masucci M.T., et al. Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis. EMBO J. 9, 467-474, 1990.
8. Ploug M., Rønne E., Behrendt N., Jensen A.L., Blasi F., Danø K. Cellular receptor for urokinase plasminogen activator. Carboxyl-terminal processing and membrane anchoring by glycosyl-phosphatidylinositol. J. Biol. Chem. 266, 1926-1933, 1991.
9. Sitrin R.G., Johnson D.R., Pan P.M., et al. Lipid raft compartmentalization of urokinase receptor signaling in human neutrophils. Am. J. Respir. Cell Mol. Biol. 30, 233-241, 2004.
10. Kjaergaard M., Hansen L.V., Jacobsen B., Gardsvoll H., Ploug M. Structure and ligand interactions of the urokinase receptor (uPAR). Front. Biosci. 13, 5441-5461, 2008.
11. Wei Y., Waltz D.A., Rao N., Drummond R.J., Rosenberg S., Chapman H.A. Identification of the urokinase receptor as an adhesion receptor for vitronectin. J. Biol. Chem. 269, 32380-32388, 1994.
12. Ragno P., Montuori N., Covelli B., Hoyer-Hansen G., Rossi G. Differential expression of a truncated form of the urokinase-type plasminogen-activator receptor in normal and tumor thyroid cells. Cancer Res. 58, 1315-1319, 1998.
13. Høyer-Hansen G., Ploug M., Behrendt N., Rønne E., Danø K. Cell-surface acceleration of urokinasecatalyzed receptor cleavage. Eur. J. Biochem. 243, 21-26, 1997.
14. Resnati M., Pallavicini I., Wang J.M., et al. The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1 /LXA4R. Proc. Natl. Acad. Sci. USA. 99, 1359-1364, 2002.
15. Le Y., Murphy P.M., Wang J.M. Formyl-peptide receptors revisited. Trends Immunol. 23, 541-548, 2002.
16. Smith H.W., Marshall C.J. Regulation of cell signalling by uPAR. Nat. Rev. Mol. Cell Biol. 11, 23-36, 2010.
17. Alfano D., Ragno P., Stoppelli M.P., Ridley A.J. RhoB regulates uPAR signalling. J. Cell Sci. 125, 2369-2380, 2012.
18. Fazioli F., Resnati M., Sidenius N., Higashimoto Y., Appella E., Blasi F. A urokinase-sensitive region of the human urokinase receptor is responsible for its chemotactic activity. EMBO J. 16, 7279-7286, 1997.
19. Montuori N., Carriero M.V., Salzano S., Rossi G., Ragno P. The cleavage of the urokinase receptor regulates its multiple functions. J. Biol. Chem. 277, 46932-46939, 2002.
20. De Paulis A., Montuori N., Prevete N., et al. Urokinase induces basophil chemotaxis through a urokinase receptor epitope that is an endogenous ligand for formyl peptide receptor-like 1 and-like 2. J. Immunol. 173, 5739-57348, 2004.
21. Montuori N., Bifulco K., Carriero M.V., et al. The cross-talk between the urokinase receptor and fMLP receptors regulates the activity of the CXCR4 chemokine receptor. Cell. Mol. Life Sci. 68, 2453-2467, 2011.
22. Høyer-Hansen G., Pessara U., Holm A., et al. Urokinase-catalysed cleavage of the urokinase receptor requires an intact glycolipid anchor. Biochem. J. 358, 673-679, 2001.
23. Selleri C., Montuori N., Ricci P., et al. In vivo activity of the cleaved form of soluble urokinase receptor: a new hematopoietic stem/progenitor cell mobilizer. Cancer Res. 66, 10885-10890, 2006.
24. Mondino A, Blasi F. uPA and uPAR in fibrinolysis, immunity and pathology. Trends Immunol. 25, 450-455, 2004.
25. Rijneveld A.W., Levi M., Florquin S., Speelman P., Carmeliet P., van Der Poll T. Urokinase receptor is necessary for adequate host defense against pneumococcal pneumonia. J. Immunol. 168, 3507-3511, 2002.
26. Gyetko M.R., Sud S., Kendall T., Fuller J.A., Newstead M.W., Standiford T.J. Urokinase receptordeficient mice have impaired neutrophil recruitment in response to pulmonary Pseudomonas aeruginosa infection. J. Immunol. 165, 1513-1519, 2000.
27. May A.E., Kanse S.M., Lund L.R., Gisler R.H., Imhof B.A., Preissner K.T. Urokinase receptor (CD87) regulates leukocyte recruitment via beta 2 integrins in vivo. J. Exp. Med. 188, 1029-1037, 1998.
28. Rijneveld A.W., Florquin S., Bresser P., et al. Plasminogen activator inhibitor type-1 deficiency does not influence the outcome of murine pneumococcal pneumonia. Blood 102, 934-939, 2003.
29. Hovius J.W., Bijlsma M.F., van der Windt G.J., et al. The urokinase receptor (uPAR) facilitates clearance of Borrelia burgdorferi. PLoS Pathog. 5, e1000447, 2009.
30. Gyetko M.R., Sud S., Sonstein J., Polak T., Sud A., Curtis J.L. Antigen-driven lymphocyte recruitment to the lung is diminished in the absence of urokinase-type plasminogen activator (uPA) receptor, but is independent of uPA. J. Immunol. 167, 5539-5542, 2001.
31. Eugen-Olsen J., Gustafson P., Sidenius N., et al. The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau. Int. J Tuberc. Lung Dis. 6, 686-692, 2002.
32. Alfano M., Sidenius N., Blasi F., Poli G. The role of urokinase-type plasminogen activator (uPA)/uPA receptor in HIV-1 infection. J. Leukoc. Biol. 74, 750-756, 2003.
33. Sidenius N., Sier C.F., Ullum H., et al. Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection. Blood. 96, 4091-4995, 2000.
34. Huttunen R., Syrjänen J., Vuento R., et al. Plasma level of soluble urokinase-type plasminogen activator receptor as a predictor of disease severity and case fatality in patients with bacteraemia: a prospective cohort study. J. Intern. Med. 270, 32-40, 2011.
35. Selleri C., Montuori N., Ricci P., et al. Involvement of the urokinase-type plasminogen activator receptor in hematopoietic stem cell mobilization. Blood 105, 2198-2205, 2005.
36. Eugen-Olsen J. suPAR-a future risk marker in bacteremia. J. Intern. Med. 270, 29-31, 2011.